NEW YORK, Sept. 27 (GenomeWeb News) - Beckman Coulter and the Immune Tolerance Network have opened a core laboratory to develop, standardize, and automate cell-based tests for clinical trials at Beckman's facility in Miami, the company said today.
Researchers from ITN, Beckman, and investigators from the USand Europeplan to develop and validate new cellular assays of T-cell responses for monitoring immune tolerance in clinical trials. "We believe that Beckman Coulter has a special expertise in these areas and look forward to working with the company in developing a number of these assays," said Hugh Auchincloss, chief operating officer of ITN, in a statement.
The Immune Tolerance Network, based at the Universityof California, San Francisco, is an international research collaboration with a dozen core facilities.
